Year: 2026
Type: article
Abstract: At a time when addiction field professionals and advocates await a decision on the possible rescheduling of marijuana, a report from Congress's Government Accountability Office (GAO) has uncovered gaps in the overall evaluations conducted by the federal agencies involved in all drug scheduling decision‐making processes.
Source: Alcoholism & Drug Abuse Weekly
DOI: 10.1002/adaw.35064
Author: Gary Enos
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7219128849